OBJECTIVES: To determine whether any particular intervention or combination of interventions is effective in the treatment, management and rehabilitation of adults and children with a diagnosis of chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME). DESIGN: Substantive update of a systematic review published in 2002. Randomized (RCTs) and non-randomized controlled trials of any intervention or combination of interventions were eligible for inclusion. Study participants could be adults or children with a diagnosis of CFS/ME based on any criteria. We searched eleven electronic databases, reference lists of articles and reviews, and textbooks on CFS/ME. Additional references were sought by contact with experts. RESULTS: Seventy studies met the inclusion criteria. Studies on behavioural, immunological, pharmacological and complementary therapies, nutritional supplements and miscellaneous other interventions were identified. Graded exercise therapy and cognitive behaviour therapy appeared to reduce symptoms and improve function based on evidence from RCTs. For most other interventions, evidence of effectiveness was inconclusive and some interventions were associated with significant adverse effects. CONCLUSIONS: Over the last five years, there has been a marked increase in the size and quality of the evidence base on interventions for CFS/ME. Some behavioural interventions have shown promising results in reducing the symptoms of CFS/ME and improving physical functioning. There is a need for research to define the characteristics of patients who would benefit from specific interventions and to develop clinically relevant objective outcome measures.
OBJECTIVES: To determine whether any particular intervention or combination of interventions is effective in the treatment, management and rehabilitation of adults and children with a diagnosis of chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME). DESIGN: Substantive update of a systematic review published in 2002. Randomized (RCTs) and non-randomized controlled trials of any intervention or combination of interventions were eligible for inclusion. Study participants could be adults or children with a diagnosis of CFS/ME based on any criteria. We searched eleven electronic databases, reference lists of articles and reviews, and textbooks on CFS/ME. Additional references were sought by contact with experts. RESULTS: Seventy studies met the inclusion criteria. Studies on behavioural, immunological, pharmacological and complementary therapies, nutritional supplements and miscellaneous other interventions were identified. Graded exercise therapy and cognitive behaviour therapy appeared to reduce symptoms and improve function based on evidence from RCTs. For most other interventions, evidence of effectiveness was inconclusive and some interventions were associated with significant adverse effects. CONCLUSIONS: Over the last five years, there has been a marked increase in the size and quality of the evidence base on interventions for CFS/ME. Some behavioural interventions have shown promising results in reducing the symptoms of CFS/ME and improving physical functioning. There is a need for research to define the characteristics of patients who would benefit from specific interventions and to develop clinically relevant objective outcome measures.
Authors: S E Straus; J K Dale; M Tobi; T Lawley; O Preble; R M Blaese; C Hallahan; W Henle Journal: N Engl J Med Date: 1988-12-29 Impact factor: 91.245
Authors: L M Forsyth; H G Preuss; A L MacDowell; L Chiazze; G D Birkmayer; J A Bellanti Journal: Ann Allergy Asthma Immunol Date: 1999-02 Impact factor: 6.347
Authors: Elaine Weatherley-Jones; Jon P Nicholl; Kate J Thomas; Gareth J Parry; Michael W McKendrick; Stephen T Green; Philip J Stanley; Sean P J Lynch Journal: J Psychosom Res Date: 2004-02 Impact factor: 3.006
Authors: P Steinberg; B E McNutt; P Marshall; C Schenck; N Lurie; A Pheley; P K Peterson Journal: J Allergy Clin Immunol Date: 1996-01 Impact factor: 10.793
Authors: V Giebels; H Repping-Wuts; G Bleijenberg; J M Kroese; N Stikkelbroeck; A Hermus Journal: J Endocrinol Invest Date: 2014-01-09 Impact factor: 4.256
Authors: Alison J Wearden; Christopher Dowrick; Carolyn Chew-Graham; Richard P Bentall; Richard K Morriss; Sarah Peters; Lisa Riste; Gerry Richardson; Karina Lovell; Graham Dunn Journal: BMJ Date: 2010-04-23
Authors: Patrick Luyten; Boudewijn Van Houdenhove; Chi-Un Pae; Stefan Kempke; Peter Van Wambeke Journal: Psychiatry Investig Date: 2008-12-31 Impact factor: 2.505